Researchers believe the protein amyloid beta-peptide (AB) plays a central role in brain cell death in Alzheimer's disease. At this briefing, Dr. Allan Butterfield describes the NIH-supported research on AB-induced neurotoxicity and its prevention by antioxidant compounds and how this relates to Alzheimer's disease. It is part of the special symposium on Neurotoxicity and Neuroprotection at the national meeting of the American Chemical Society, the world's largest scientific society, taking place in Boston, August 23-27.

WHO:

Allan Butterfield, Ph.D., Director, Center for Membrane Sciences and Faculty Associate,
Sanders-Brown Center for Aging, University of Kentucky

WHAT:

Alzheimer's Disease Briefing

WHEN:

Thursday, August 27, 1998 12:30 p.m.

WHERE:

Sheraton Boston Beacon Suite A

For Further Information Contact:

Nancy Blount, (202) 872-4451 August 20-27: Press Room, Convention Center, Room 308
Phone: (617) 351-6808; Fax: (617) 351-6820

A nonprofit organization with a membership of more than 155,000 chemists an chemical engineers as its members, the American Chemical Society publishes scientific journals and databases, convenes major research conferences, and provides educational, science policy and career programs in chemistry. Its main offices are in Washington, D.C., and Columbus, Ohio.